Revenue segments as reported by the company.

Net revenue, before excise taxes

Excise taxes

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

Research and development

General and administrative

Restructuring costs

Share-based payments

Depreciation and amortization

Impairment loss on goodwill and indefinite-lived intangible assets

Impairment loss on long-lived assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cronos Group

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

Ginkgo Bioworks Holdings

Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares are trading higher by 7.63% to $2.68 after the company, and Cronos Group Inc (NASDAQ: CRON), announced the achievement of the third target productivity milestone in their partnership to produce eight cultured cannabinoids. Using Ginkgo's platform.

Why Ginkgo Bioworks Shares Are Rising After Announcement With Partner Cronos Group

Aurora Cannabis

AFC Gamma

Canopy Growth

Amplify Seymour Cannabis ETF

Curaleaf Holdings, Inc.

GrowGeneration Corp

Hydrofarm Holdings Group

Innovative Industrial Properties

Amplify Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

NewLake Capital Partners, Inc.

Global X Cannabis ETF

Power REIT

Chicago Atlantic Real Estate Finance

Scotts Miracle-Gro

Trulieve Cannabis Corp.

Tilray Brands

Cambria Cannabis ETF

Village Farms International

AdvisorShares Pure Cannabis ETF 

Cannabis REITs - a perennial performance leader over the past half-decade - have been slammed in 2022 amid concerns over tenant financial health given the sharp re-pricing of risk and tighter financial conditions. Owning the "Pharmland" - the physical real estate - had been one of the few cannabis plays that was working amid a decade-long stretch of dismal investment performance from broader cannabis ETFs.

Cannabis REITs: Weeding Out The Weak

TORONTO and BOSTON , June 21, 2022 /PRNewswire/ -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos"), an innovative global cannabinoid company, and Ginkgo Bioworks (NYSE: DNA) ("Ginkgo"), the leading horizontal platform for cell programming, today announced the achievement of the third target productivity milestone in their partnership to produce eight cultured cannabinoids. Using Ginkgo's platform for organism design and development, Cronos has successfully achieved the productivity target for tetrahydrocannabivarin (THCV), a cannabinoid hypothesized to reduce the appetite-enhancing property of THC.

Cronos Group and Ginkgo Bioworks Announce Achievement of THCV Equity Milestone

Canadian Pot Stocks For Short Term Trading In June The post Are Canadian Marijuana Stocks A Buy Right Now? 3 With Fresh Lows This Week appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Are Canadian Marijuana Stocks A Buy Right Now? 3 With Fresh Lows This Week

SNDL Inc.

3 Top Marijuana Stocks To Watch For Better Trading In June The post 3 Marijuana Stocks To Buy In June 2022? appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

3 Marijuana Stocks To Buy In June 2022?

3 Canadian Marijuana Stocks To Watch At The End Of The Month The post Top Canadian Marijuana Stocks To Watch This June appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Canadian Marijuana Stocks To Watch This June

OrganiGram Holdings Inc.

Are You Ready To Buy Canadian Marijuana Stocks? The post Are These The Best Canadian Marijuana Stocks To Buy In 2022? appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Are These The Best Canadian Marijuana Stocks To Buy In 2022?

Cronos Group Inc. (NASDAQ:CRON ) 17th Annual BMO Capital Markets Global Farm to Market Conference May 19, 2022 2:00 PM ET Company Participants Mike Gorenstein - Chairman, President and Chief Executive Officer Conference Call Participants Tamy Chen - BMO Capital Market Operator …..abrupt start Or making those changes.

Cronos Group Inc. (CRON) CEO Mike Gorenstein presents at 17th Annual BMO Capital Markets Global Farm to Market Conference (Transcript)

Marijuana Stocks To Watch While The Sector Is Down The post Are Canadian Marijuana Stocks A Buy Right Now? 3 For Your List In May appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Are Canadian Marijuana Stocks A Buy Right Now? 3 For Your List In May

Agrify

Emerald Expositions Events

High Tide

Akerna Corp

WM Technology

Urban-gro

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks this week, and look ahead to how the cannabis industry will continue to develop in 2022.

12 Cannabis Stocks in the Red and Still Making Headlines

Are These Marijuana Stocks Going To See Higher Market Levels The post 3 Marijuana Stocks To Watch During The 2nd Week Of May appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

3 Marijuana Stocks To Watch During The 2nd Week Of May

TORONTO, May 10, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and Chief Executive Office, will speak at two upcoming conferences:

Cronos Group Inc. Announces Conference Participation for May 2022

The company missed on earnings but investors were happy with its first-quarter revenue growth numbers.

Why Cronos Group Stock Soared 13.8% Today

Cronos Group Inc. CRON, +15.55% shares jumped 14% on Tuesday after the cannabis company's first-quarter revenue of $25 million beat the analyst estimate by $1 million. Raymond James analyst Rahul Sarugaser reiterated an outperform rating on the stock and said Cronos also reported a better-than-expected adjusted Ebitda loss of $18.9 million, against a target for an adjusted Ebitda loss of $27.5 million.

Cronos shares rally as investors cheer latest results

Cronos Group Inc. (NASDAQ:CRON ) Q1 2022 Earnings Conference Call May 10, 2022 8:30 AM ET Company Participants Shayne Laidlaw - IR Mike Gorenstein - Chairman, President and CEO Bob Madore - CFO Conference Call Participants Michael Frieden - Raymond James John Zamparo - CIBC Andrew Carter - Stifel Matt Bottomley - Canaccord Gaurav Jain - Barclays Operator Good morning, my name is Amanda, and I will be your conference operator today. I would like to welcome everyone to Cronos Group 2022 First Quarter Earnings Conference Call.

Cronos Group Inc. (CRON) CEO Mike Gorenstein on Q1 2022 Results - Earnings Call Transcript

Cronos (CRON) delivered earnings and revenue surprises of 0% and 7.58%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Cronos Group (CRON) Reports Q1 Loss, Tops Revenue Estimates

Revenue gains are driven by growth of the Israeli medical market and Canadian adult-use market.

Cronos Group Doubles Sales, Thanks to Growth in Canada and Israel

Cronos Group CRON, -4.39% said Tuesday its first-quarter net loss narrowed to $16.42 million, or 9 cents a share, from a loss of $146.2 million, or 44 cents a share, in the year-ago quarter. Revenue doubled to $25.03 million from $12.61 million.

Cannabis company Cronos Group doubles revenue, beats analyst target

Consolidated net revenue increased by 99% year-over-year to $25.0 million in Q1 2022

Cronos Group Reports 2022 First Quarter Results

Hut 8 Mining Corp

Kinross Gold

Transocean

When picking the best stocks under $10 to buy, it's important to identify fundamentally strong and non-speculative stocks. The post 4 Stocks Under $10 That Could Double By December 2022 appeared first on InvestorPlace.

4 Stocks Under $10 That Could Double By December 2022

3 Canadian Marijuana Stocks To Watch This Upcoming Week The post 3 Canadian Marijuana Stocks To Watch Next Week appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

3 Canadian Marijuana Stocks To Watch Next Week

AMC Entertainment

Hecla Mining

Li Auto Inc.

Peloton

All three major U.S. equity indexes were slammed Thursday, dropping by 3% to 5%. In the first hour of trading, all the previous day's gains were wiped out.

Earnings Previews: AMC Entertainment, Cronos, Hecla Mining, Li Auto, Peloton

TORONTO, April 29, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its 2022 Annual Meeting of Shareholders on Thursday, June 23, 2022, at 11:00 a.m. ET.

Cronos Group Inc. to Hold Virtual 2022 Annual Meeting of Shareholders

These top cannabis stocks are worth buying after a deep correction, as they can rally on hopes of more states legalizing marijuana. The post 3 Top Cannabis Stocks to Buy as State Legalization Grows appeared first on InvestorPlace.

3 Top Cannabis Stocks to Buy as State Legalization Grows

New York, New York--(Newsfile Corp. - April 28, 2022) - Sphynx Labs continues to integrate other Blockchains into its Ecosystem, and this time, they are on Cronos Network. The Team of Sphynx Labs will introduce its token called SPHYNX to be traded on Cronos.Sphynx Labs on CronosTo view an enhanced version of this graphic, please visit:

Cronos is Welcoming Sphynx Labs to its Network

News for Cronos Group Stock (CRON)